IPARINTERPARFUMS INC
Health Care
Net Income (Loss) Attributable to Parent revised up 23.2% for FY 2023
This is the 6th largest revision in IPAR's history.
Net Income (Loss) Attributable to Parent·FY 2023
Major restatement$188M▲ 23.2%
was$152.7M
Revised up. Any P/E built on the original was 18.8% too high.
Verify against SEC filingsShow
As reported$152.7M
Accepted 2024-02-270001753926-24-000405
Restated$188M
Accepted 2026-07-310001753926-26-001295
NetIncome · reported 4 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time IPAR — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.